Research institutions: University, Biozentrum, Friedrich Miescher Institute, ETH

Read the PDF edition (2 pages)

The life sciences cluster of Basel rests on a dense network of public and private research institutions. The University of Basel, whose foundation in 1460 Part A described, has developed a strong profile in the life sciences. Its Biozentrum, founded in 1971, was one of the first interdisciplinary institutes of molecular biology in Europe. It brought together biochemistry, biophysics, cell biology, microbiology, pharmacology and structural biology under one roof. Several of its researchers have received the Nobel Prize, among them Werner Arber in 1978 for his work on restriction enzymes.¹ In 2021 the Biozentrum moved into a new research tower on the Schällemätteli site, whose construction was marked by long delays and cost overruns that became a subject of political debate in the two sponsoring cantons.²

The Friedrich Miescher Institute for Biomedical Research, named after the Basel physician who discovered nucleic acids in 1869, was founded in 1970 by the newly merged Ciba-Geigy and is today affiliated with the Novartis Research Foundation. It conducts basic research in neurobiology, epigenetics and quantitative biology and is associated with the University of Basel.³ The combination of a corporate foundation and academic affiliation is characteristic of the Basel model, in which the boundary between public and private research is permeable.

In 2006 the Swiss Federal Institute of Technology in Zurich (ETH Zurich) established its Department of Biosystems Science and Engineering (D-BSSE) in Basel. It was the first ETH department outside Zurich, a decision that reflected the attraction of the Basel cluster for engineering approaches to biology. The department has moved into a new building on the Schällemätteli site, next to the Biozentrum and the university hospital.⁴ The Swiss Tropical and Public Health Institute, the University Hospital, the University Children's Hospital and the research units of the large groups complete the scientific landscape. Their proximity forms the basis of the cluster that the cantons promote.

Notes

On the foundation of the Biozentrum of the University of Basel in 1971 and the Nobel Prize in Physiology or Medicine 1978 awarded to Werner Arber, see the history of the Biozentrum published by the University of Basel and the Nobel Foundation. To be verified. ↩
On the new Biozentrum building (completed 2021) and the delays and cost overruns of the project, see the reports of the governments and parliaments of Basel-Stadt and Basel-Landschaft. Status to be verified. ↩
On the Friedrich Miescher Institute for Biomedical Research (FMI), founded in 1970 and part of the Novartis Research Foundation, and on Friedrich Miescher's discovery of "nuclein" in 1869, see the FMI website and the history of science literature. To be verified. ↩
On the establishment of the ETH Zurich Department of Biosystems Science and Engineering (D-BSSE) in Basel in 2006 and its new building at Schällemätteli, see the ETH Zurich website. Status to be verified. ↩

For general information only. This article does not constitute legal or tax advice, does not replace advice on an individual case and creates no lawyer-client relationship. It reflects the legal position as of August 2025.

English

Contact

Dr Alexander Ressos, TEP

Rechtsanwalt/Attorney-at-Law

I am a Swiss attorney-at-law and also admitted as a solicitor in Hong Kong and in England & Wales, with almost 25 years of experience.

Together with my multilingual team, including Chinese, Japanese, Korean, Russian, Ukrainian and French native speakers, I advise companies and their owners from around the world on the full range of banking, corporate, commercial and tax law matters in Switzerland, including international tax planning, fiduciary services, and legal family office services including immigration & relocation or real estate investments. My practice has a particular focus on clients from growth and frontier markets in Greater China, Central Asia and the Caucasus, the rest of Asia, the Middle East, Africa and Latin America, and I equally advise clients from Europe and North America. Through an affiliated Swiss trust company, we also take care of the incorporation and ongoing administration of their companies and other structures, including accounting, tax returns and corporate secretarial services, and I serve as a professional director where required. With the support of a network of first-class cooperation partners, I also implement solutions worldwide.

My approach is to act as a trusted advisor who works directly with decision-makers, on an equal footing: I start from what you want to achieve and shape every structure, contract and tax decision around your commercial goals and how it improves your after-tax return. As “lawyers who make it happen”, my team and I stay involved until your company is set up, your structure is in place and your transaction has closed, and we remain available for any follow-on work that may be required. You benefit from bespoke solutions and personal attention, and sound, friendly and practical advice. We are not the lowest-cost provider in the market, nor do we intend to be; our aim is to deliver well-founded, proper solutions and excellent value for money.

Get in touch →

Research institutions: University, Biozentrum, Friedrich Miescher Institute, ETH

Notes

Setting up or expanding in Switzerland?